Department of Obstetrics and Gynaecology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Hum Reprod. 2011 Jul;26(7):1899-904. doi: 10.1093/humrep/der141. Epub 2011 May 15.
Long-term effects of laparoscopic electrocautery of the ovaries are unknown. To study the long-term effects of laparoscopic electrocautery of the ovaries and gonadotrophins, we followed women with clomiphene-resistant polycystic ovary syndrome (PCOS) randomly allocated to one of these treatments until 8-12 years after their initial treatment.
Between February 1998 and October 2001 168 women with clomiphene citrate-resistant PCOS were included in a randomized controlled trial comparing an electrocautery strategy to a strategy starting with rFSH. In 2009 these women were contacted about their reproductive outcome and menstrual cycle regularity. Analysis was by intention-to-treat. We compared time to conception resulting in live birth, subsequent pregnancies, ectopic and multiple pregnancies, menopause, as well as minimal and maximal menstrual cycle length.
After 8-12 years, the cumulative proportion of women with a first child was 86% in women who had been allocated to electrocautery versus 81% in women who had been allocated to immediate rFSH [relative ratio (RR): 1.1; 95% confidence interval (CI): 0.92-1.2]. Treatment with electrocautery resulted in a significantly lower need for stimulated cycles to reach a live birth; 53% after electrocautery versus 76% after rFSH (RR: 0.69; 95% CI: 0.55-0.88).The cumulative proportion of women with a second child was 61% after electrocautery versus 46% after immediate rFSH (RR: 1.4; 95% CI: 1.00-1.9). Overall, there were 7 twins out of 134 deliveries (5%) after electrocautery versus 10 twins out of 124 deliveries (8%) in the rFSH group (RR: 0.65; 95% CI: 0.25-1.6). Fifty-four per cent of the women allocated to electrocautery had a regular menstrual cycle 8-12 years after randomization versus 36% in those allocated to rFSH (RR: 1.5; 95% CI: 0.87-2.6).
In women with clomiphene-resistant PCOS, laparoscopic electrocautery of the ovaries is as effective as ovulation induction with FSH treatment in terms of live births, but reduces the need for ovulation induction or ART in a significantly higher proportion of women and increases the chance for a second child. Clinicians may use these data when informing clomiphene-resistant anovulatory women about treatment options.
腹腔镜卵巢电灼术的长期效果尚不清楚。为了研究腹腔镜卵巢电灼术和促性腺激素对长期的影响,我们对接受过氯米芬耐药多囊卵巢综合征(PCOS)治疗的女性进行了随机分配,分别接受这两种治疗方法,随访时间为初始治疗后 8-12 年。
1998 年 2 月至 2001 年 10 月,168 例氯米芬耐药的多囊卵巢综合征患者纳入一项随机对照试验,比较了电灼策略与从 rFSH 开始的策略。2009 年,我们联系了这些女性,了解她们的生殖结局和月经周期规律。分析采用意向治疗。我们比较了受孕时间、后续妊娠、异位妊娠和多胎妊娠、绝经以及最小和最大月经周期长度。
8-12 年后,接受电灼治疗的女性中,有 86%的人首次生育,而接受 rFSH 即刻治疗的女性中,有 81%的人首次生育(相对比值 1.1;95%置信区间 0.92-1.2)。电灼治疗需要接受刺激周期以达到活产的比例显著降低;电灼治疗组为 53%,而 rFSH 治疗组为 76%(相对比值 0.69;95%置信区间 0.55-0.88)。电灼治疗组中有 61%的女性再次生育,而 rFSH 治疗组中则有 46%(相对比值 1.4;95%置信区间 1.00-1.9)。总的来说,电灼组有 7 对双胞胎(5%),而 rFSH 组有 10 对双胞胎(8%)(相对比值 0.65;95%置信区间 0.25-1.6)。随机分组后 8-12 年,接受电灼治疗的女性中,54%的人月经周期规律,而接受 rFSH 治疗的女性中,36%的人月经周期规律(相对比值 1.5;95%置信区间 0.87-2.6)。
对于氯米芬耐药的 PCOS 患者,腹腔镜卵巢电灼术与 FSH 治疗排卵诱导在活产方面同样有效,但在更高比例的女性中降低了排卵诱导或 ART 的需求,并增加了再次生育的机会。临床医生在为氯米芬耐药性无排卵女性提供治疗选择时,可以参考这些数据。